Resultados de la búsqueda 521-530 of 4561 for SARS-CoV-2

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... II, maintenance), with some patients randomized to receive inotuzumab. Other ... II dose (RP2D of APG2575 in combination with Pomalidomide ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of ths study is to find out more about the side effects of two new drug combinations for lymphoma, TTI-621 and pembrolizumab and TTI-622 and ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    In Part 2 Cohort 1, an expansion phase at the established RP2D will be undertaken in participants with selected advanced solid tumors. In Part 2 Cohort 2, a ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    To investigate the efficacy of autologous Epstein-barr virus ... 2 weeks) to see if the effects of the treatments ... Patients will receive VSL#3® 450B sachets ...

  5. Mayo Clinic Ophthalmology Physician Update - August 2023

    Page 1.

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase II trials studies how well acalabrutinib with or without obinutuzumab works in treating participants with early-stage chronic lymphocytic leukemia or ...

  7. Mayo Clinic PM&R Physician Update - June 2023

    Page 1.

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...

  9. Neurología - Ensayos clínicos - Mayo Clinic

    ... (2) Cohort 2 focuses on primary or secondary myelofibrosis (MF) displaying mutated calreticulin (muCALR); (3) Cohort 3 focuses on glioblastoma multiforme ...

  10. Cirugía - Ensayos clínicos - Mayo Clinic

    Some patients undergoing trigger finger surgery with a pre-existing Dupuytren's cord may develop a thickened surgical scar after surgery, which can cause ...